![]() Financial Daily from THE HINDU group of publications Tuesday, Jul 26, 2005 |
|
|
|
|
|
Corporate Results
-
Pharmaceuticals Cipla Q1 net rises 40 pc Our Bureau
MUMBAI: THE Mumbai-based drug company Cipla has posted a 40 per cent growth in net profit for the three months period ended June 30, 2005. Operating margins improved due to a better product mix, a company official told Business Line. Cipla posted a net profit of Rs 111.4 crore for the first quarter as compared to Rs 79.2 crore clocked for the same period in the previous year, the company told the Bombay Stock Exchange. Total income (net of excise) increased from Rs 545.3 crore in the first quarter of 2004to Rs 671.1 crore for the quarter under review. Further, the company posted a net profit of Rs 409.61 crore for the year ended March 31, 2005, as compared to Rs 316.3 crore for the year ended March 31, 2004. Total income (net of excise) increased from Rs 1,958.5 crore in the fiscal ended March 2004 to Rs 2,336.4 crore for the year ended March 31, 2005. Cipla's board of directors has also recommended a payment of dividend of Rs 3.50 per equity share (face value of Rs 2) for the year ended 2004-2005 amounting to Rs 104.95 crore.
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2005, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|